quences. We also demonstrate by site-directed mutagenesis that changes to these predicted motifs affect transport function. It thus appears that the transport signal of HlyA may be defined by a higher-order structure and that the hemolysin transporter may recognize a much wider diversity of primary sequences than previously anticipated. This finding may have implications for understanding the basis of substrate specificity of other ATP binding cassette transporters.
Hemolysin A (HlyA) is secreted directly from the cytoplasm of Escherichia coli into the surrounding medium without accumulation in the periplasmic space (1) . It is dependent on the inner membrane proteins hemolysin B (HlyB) and hemolysin D (HlyD) (2, 3) and an outer membrane protein TolC (4) . HlyB is a member of the superfamily of ATP binding cassette transporters involved in the translocation of diverse substrates across biological membranes in prokaryotes and eukaryotes. These include ions, peptides, large proteins, and sugar polymers (5, 6) . Recognition of HlyA by the transporter may be initiated by an interaction of HlyB with the C-terminal sequence of HlyA (F.Z., J. Sheps, and V.L., unpublished data). This C-terminal signal sequence has been localized to approximately the last 50 amino acids (7) (8) (9) (10) . In addition, many proteins that are not normally secreted by E. coli are secreted by the hemolysin transporter when engineered to contain the C terminus of HlyA (10, 11) . Results from studies of such chimeric proteins indicate that the C-terminal signal sequence contains all the information required for transport.
The structural feature of the HlyA C-terminal region required for transport by the HlyB/D system is not understood and may be complex (12, 13) . In the present study, we show that a 70-amino acid sequence of leukotoxin (LktA) of Pasteurella hemolytica (14) can function efficiently as a signal sequence for the hemolysin transporter. This sequence has little similarity with the signal sequence of HlyA. These results raise the intriguing possibility that the hemolysin system is able to recognize a diversity of structures for transport. This may be a characteristic feature of other ATP binding cassette transporters.
MATERIALS AND METHODS
Bacterial Strains and Plasmids. The E. coli strain JM83 was used for hemolytic assays. E. coli Bw313 and JmlO9 were used for oligonucleotide-directed mutagenesis (15) . Plasmids pLG570 (16), pLG583, pLG579 (17) , pLG594 (18) , and N32 (2) were used to construct pLG583sk, pTG653, and pLGCD. Plasmids pLG570, pLG579, pLG583, and pLG594 were kindly provided by I. B. Holland (University Paris-Sud, Cedex, France). Plasmid pLKT5 (19) , kindly provided by R. C. Lo (University of Guelph, Ontario, Canada), was used to construct pHA/lkt.
Construction of Plasmids Containing Different Hemolysin Genes. Four genes of the hemolysin system were cloned into three plasmids: hlyA in pLG583sk, hlyB in pTG653, hlyC and hlyD in pLGCD. We introduced two restriction sites, Sal I (nucleotide position 2892 of hlyA) and Kpn I (downstream of hlyA) into hlyA-containing plasmid pLG583 by ligating the Bgl Il/Sal I (blunt ended) large fragment of pLG583 with the Bgl II/EcoRV small fragment of N32 followed by sitedirected mutagenesis with the oligonucleotide 5'-CATGAT-GCGTCGACTTATGG-3'. The resulting plasmid was designated pLG583sk. A Bgl II/EcoRI fragment bearing the hlyB gene from pLG579 was inserted into pTZ18R (Pharmacia) at the EcoRI and BamHI sites and was named pTG653. pLGCD was constructed by inserting the Pvu II fragment bearing the hlyC gene from pLG570 into the hlyD-bearing plasmid pLG594 at the Sal I (blunt ended) site. Routine cloning procedures were carried out essentially as described by Sambrook et al. (20 TAGTTCGCGAGGAATGTA) resulting in a new amino acid terminal at position 958 (YVYGHDASTag) (lowercase letters represent mutant amino acids). pHAcr-1 was obtained in a separate experiment (F.Z., unpublished results) in which a degenerate oligonucleotide was used to generate mutants in this region. The resulting sequence is at position 2962 (GG-TAATTTGGATGTTAAGGAGGAAGATCTGCCGCT-TCT). pHAcr-2 was constructed by ligation of the large Bgl II (blunt ended)/Sma I fragment of pHAcr-1 (which contains the main part of hlyA) with the 4-kb Sal I (blunt ended)/Sma I fragment of pLG583. pHAcr-3 was made by ligating the large Bgl II/Kpn I (blunt ended) fragment of pHAcr-1 with the 190-bp BamHI/EcoRV fragment of pBR322. pHAed-1 and pHAtd were constructed by site-directed mutagenesis of pLG583sk using oligonucleotides 5'-GCTGCAGGTAACT-TCTCTGCAGCTTCT-3' and 5'-GCAAAATCATTTCA-GATGTTAAGGAGG-3', respectively. pHAad was resolved from self-ligation of the Sal I (blunt ended) and Bgl II (blunt ended) large fragment of pLG583sk.
Hemolytic Assay. Measurement of secreted HlyA: JM83 cells harboring pTG653 (HlyB), pLGCD (HlyC, -D) and the desired HlyA-bearing plasmids were grown in LB medium with kanamycin (50 ,ug/ml), ampicillin (50 ,ug/ml), and chloramphenicol (25 ,ug/ml) and were harvested at different times during cell growth (A600). Cells were removed by a short spin in the microcentrifuge. An aliquot of supernatant was incu- Detection of the Secreted Wild-Type and Mutant HlyA Proteins. JM83 cells harboring pTG653, pLGCD, and the desired HlyA-bearing plasmids were grown in LB medium with appropriate antibiotics and harvested at A600 = 1. The cells were removed by centrifugation at 3000 x g for 10 min. Trichloroacetic acid was added to the supernatant to a final concentration of 10% (vol/vol), and the sample was incubated on ice for >1 hr. After centrifugation (8000 x g; 15 min), the precipitated proteins were dissolved in 250 mM NaOH/50 mM Tris HCl, separated by SDS/PAGE (21) using a 3% stacking and an 11% separating gel, and visualized by staining with Coomassie brilliant blue R-250. The prominent 107-kDa band in Fig. 2 (lane 1) was identified to be HlyA protein by Western blot analysis (data not shown).
Protein Secondary Structure Prediction Analysis. Secondary structure predictions were made from protein primary sequences using the package SECSTR (22) , kindly provided by S. Hamodrakas and F. P. Ottensmeyer (Ontario Cancer Institute). The program was run on an IBM PS/2 model 70 386 personal computer.
RESULTS
Evaluation of the C-Terminal Sequence of LktA as a HlyA Transport Signal. Previously it has been reported that LktA can be secreted by the E. coli hemolysin transport system (19, 23) . However, the presumptive signal sequence has not been defined nor has the efficiency of secretion been quantified.
Our expectation was that the signal sequence in LktA would be located at the C-terminal portion of the molecule as it is in HlyA. To test this possibility, we replaced the C-terminal 58 amino acids of HlyA (amino acids 967-1024) with the 143 C-terminal amino acids of LktA (amino acids 811-953) (HlyA/lktl43; Fig. 1C ) and assayed the ability of this chimeric protein to be transported by the hemolysin system.
As shown in Fig. 2 (1, 9, 10, 12) . We therefore determined whether any higher-order structures could be observed in common between the HlyA and LktA C-terminal sequences. We used a secondary structure prediction program described by Hamodrakas (22) , which involves six different methods. Prominent predicted secondary structure motifs of helix-turn-helix and strand-loop-strand were observed in both sequences and this is summarized in Fig. 1B .
These structure motifs correspond to the C-terminal 58 amino acids of HlyA and the C-terminal 70 amino acids of LktA. We reasoned therefore that ifthese structural motifs are sufficient for transport, then the C-terminal 70 amino acids of LktA should function as well as the C-terminal 143 amino acids (construct HlyA/lktl43 of Fig. 1C ). To test this prediction, we replaced, as described above, the 58 amino acids of the HlyA C terminus with the LktA C-terminal 70 amino acids (HlyA/ lkt7O; Fig. 1C ). As shown in Fig. 2 The relative transport efficiencies of these mutant constructs were estimated as a percentage of wild type by determining the hemolytic activity in the medium (Fig. 3) and by the amount of secreted HlyA protein in the medium as visualized by SDS/PAGE (Fig. 2) . These two measurements rank correlated identically.
Fig . 3B illustrates the functional involvement of the predicted helix-turn-helix motif. In mutant 1 (pLG634), previously described by Mackman et tion in the same region (mutant 2) still retained a substantial ability to be transported (8 be explained in light of our current findings. We note that in mutant 2, a predicted helix-turn-helix structure originally present upstream from the signal sequence was brought into register by the deletion and thus restored the signal for transport. Such a rearrangement did not occur in mutant 1 since a predicted helix-loop-strand structure was brought into the proximity ofthe C-terminal sequence by the deletion. When we constructed mutant 3 (HlyAad), containing a 30-amino acid (amino acids 966-995) deletion in this region, we observed that HlyA transport was decreased to 6% (see also Fig. 2, lane 7) . In this instance, the upstream sequence brought into proximity of the C terminus did not contain a predicted helix-turn-helix motif, again indicating the importance of this predicted motif in the signal sequence.
In a similar context, previous investigation (Fig. 3B , mutant 4) revealed that the deletion of 11 amino acids at positions 988-998 resulted in the abolition of transport (9) . The authors suggested that the cluster of charged amino acids, DVKEER, in this region may be critical for function. A more recent mutational analysis by the same group suggests that uncharged amino acids surrounding this region may also be important (12) . Based on our current study, the 11-amino acid deletion would also eliminate the turn in the predicted helix-turn-helix motif and this would result in a predicted single extended helix (see Fig. 3B, mutant 4) . When we constructed mutant 5 to eliminate only the cluster of Transport efficiencies of the mutants constructed in this study were determined by a hemolytic assay and are expressed as percentage of wild type. These data are derived from three or more independent experiments with duplicate samples. Results are presented as means ± SD. Transport efficiencies of mutants 1, 2, and 4 are estimated based on data described in the original publications (8, 9) . Solid bar, a-helix; zigzag line, (3- Fig. 2, lane 3) . This indicates that this predicted turn structure may be a critical feature of this region.
Mutations in the Predicted Strand-Loop-Strand Structure. The C-terminal 27 amino acids of HlyA contain the predicted strand-loop-strand motif (Fig. 3A) . To examine the structural requirements of this region for transport, we analyzed three HlyA mutants in which the last 29 amino acids were replaced with random sequences of different lengths (Fig.  3C) . In mutants 7 and 8, the addition of 6 and 18 amino acids, respectively, to the truncated molecule resulted in no observable transport, whereas in mutant 9 the addition of 22 amino acids resulted in an observed transport efficiency of -19% (see also Fig. 2, lane 5) . It should be noted that in mutant 9, a predicted strand-loop-strand motif was intro-A B.yA (wildtype) L---------ir---n duced fortuitously into the C-terminal sequence. Although this region awaits more systematic study, the mutation data along with the fact that the LktA C-terminal 70 amino acids also contain a predicted strand-loop-strand structure suggest that this predicted structure in the C terminus is required for transport function. DISCUSSION We show in this study that a 70-amino acid C-terminal sequence of LktA is fully efficient as a signal sequence for the hemolysin transport system. This sequence has no primary sequence similarity to the 50-amino acid signal sequence of HlyA. This finding implies that the transport signal of HlyA is not determined by a unique primary sequence.
In addition to the leukotoxin, the hemolysin transporter has been reported to transport proteins such as adenylate cyclase toxin in Bordetella pertussis (24) , metalloprotease B in Erwinia chrysanthemi (25) , and colicin V in E. coli (26) . However, the relative efficiency with which the hemolysin transporter is able to transport these proteins compared to HlyA is not known since different expression systems were used. In our study, a single reporter protein was used for testing the signal sequence from LktA and this enabled us to compare directly the relative transport efficiencies of two different transport signals in a quantitative manner.
The fact that the hemolysin transporter is able to utilize C-terminal peptides from HlyA and LktA as transport signals with equal efficiency is surprising. Such peptides are predicted to form similar secondary structures. The functional association with a predicted structure of helix-turn-helix and strand-loop-strand is apparently consistent with the six deletion mutants generated in this study and with three other deletion mutants generated previously. We have not extended such an analysis to a large collection of point mutations described recently (12, 13) ; however, it appears from a preliminary examination that not all such mutants are compatible with our secondary structure prediction. Thus, it appears that the basis for the recognition of the HlyA transport signal is complex and may involve an as yet unidentified higher-order structure. It is also worth noting that the exact number of residues required in the predicted secondary structural elements, especially the turns, seems to be variable. Consequently, the molecular surfaces presented by these peptides to the transporter are likely to be quite different. This raises the intriguing possibility that the hemolysin transporter is able to recognize as substrates an unexpected diversity of structures.
Understanding the basis for the broad specificity of the hemolysin transporter may provide insights into the mechanism of other ATP binding cassette transporters. The hemolysin transporter is able to utilize peptides with different primary sequences as transport signals. By analogy, the major histocompatibility complex-linked transporter of antigenic peptides (27) involved in translocating a broad range of peptides into the lumen of the endoplasmic reticulum may function in a similar manner. There is evidence that P-glycoprotein (Pgp), a transporter associated with multidrug resistance (MDR) to anticancer drugs, may function as a transporter of peptides in mammalian cells (28) (29) (30) (31) (32) . Consequently, there are speculations that the normal substrate for Pgp may be a peptide, possibly a hormone or a growth factor. Ifthis is so, the implication is that the native substrate for Pgp may not be limited to a single peptide with a unique sequence but may involve a family of peptides with some common higher-order structure. It may also be speculated that the MDR phenotype is the result of the fact that drugs involved in such a phenotype fortuitously mimic certain aspects of the higher-order structure recognized by Pgp.
